Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Hairbac tablet and oil significantly improve hair texture, density, and reduce hair loss without side effects.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

PCA hydrogel promotes hair growth by enhancing blood vessel formation and hair follicle stem cell activity.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Baricitinib effectively treated hair loss and inflammation in a patient with alopecia areata and lichen planopilaris.

Flutamide and CPA are more effective than finasteride for treating acne in hyperandrogenic women.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Off-pump heart surgery reduces complications without affecting survival rates compared to on-pump surgery.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

New mutations in MBTPS2 reduce its function and cause IFAP syndrome with unusual symptoms.

AP collagen peptides may help hair grow better and become stronger.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Baricitinib was effective in treating both early and late onset alopecia areata.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

The A-T advancement flap is a safe and effective method for scalp reconstruction after basal cell carcinoma removal.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

Adiantum capillus extract reduces pain and swelling in animals.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.